Advertisement
Home 2019

Archives

Colorectal surgery patients treated as part of an enhanced recovery after surgery (ERAS) program have less pain and use nearly half as many opioids as pre-ERAS patients

ASA: Enhanced Recovery Program Cuts Opioid Use After Colorectal Surgery

0
Findings show colorectal surgical patients can better manage pain with fewer opioids
Opioids are commonly not needed but are overprescribed at discharge among women who undergo cesarean deliveries (CDs)

ASA: Unnecessary Opioids Often Prescribed After C-Section

0
Change in computerized order sets reduces use of oxycodone to treat pain after cesarean delivery
For patients with chronic obstructive pulmonary disease

CHEST: Metoprolol Does Not Cut Time to COPD Exacerbation

0
Trial stopped early due to futility with respect to primary end point and safety concerns
Abnormal menstrual cycle characteristics are associated with elevated mortality risk

Abnormal Menstrual Cycle Linked to Elevated Mortality

0
Women reporting irregular menstrual cycle at 14 to 17, 18 to 22 more likely to die from any causes
Observation should be the standard approach after a prostatectomy for men with localized prostate cancer

Many Can Avoid RT After Surgery for Localized Prostate Cancer

0
Progression-free survival no different at five years when radiotherapy is used only if the cancer returns
A triplet combination of therapies (encorafenib

Triplet Tx Ups Survival in BRAF V600E-Mutated Colorectal Cancer

0
Overall survival longer for encorafenib, cetuximab, and binimetinib combo versus standard therapy
The addition of abemaciclib to fulvestrant provides a statistically significant and clinically meaningful gain in median overall survival

Drug Combo Extends Survival in Advanced Breast Cancer

0
Benefit seen for addition of CDK4/6 inhibitor after progression of disease on endocrine therapy
A novel machine learning-derived risk score can predict the risk for heart failure among outpatients with type 2 diabetes mellitus

Risk Tool Can Predict Heart Failure in Patients With Diabetes

0
AI model integrates readily available clinical, laboratory, and electrocardiographic data
Moderate therapeutic hypothermia for 24 hours is associated with improvement in favorable neurologic outcome at 90 days among patients with persistent coma who have been resuscitated from cardiac arrest with nonshockable rhythm

Hypothermia Aids Cardiac Arrest With Nonshockable Rhythm

0
Higher percentage of patients survived with favorable neurologic outcome at day 90
For patients with progressive fibrosing interstitial lung diseases

Nintedanib Slows Fibrosing Interstitial Lung Disease

0
Nintedanib linked to lower rate of decline in forced vital capacity versus placebo in phase 3 trial